AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (3 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access | Just Accepted

Brain-targeting peptide-modified Ginkgo biloba leaf-derived exosome-like nanoparticles for ischemic stroke therapy

Bo Zhao1, Xinchi Jiang2, Wanshu Li1, Lixia Chen1, Yuhao Zhang1, Yuli Gao1, Yaosheng Li2, Yuankai Sun2, Hui Liu2, Juanjuan Zheng2, Jianqing Gao2 ( ), Hangjuan Lin1 ( )

1 Department of Pharmacy, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo 315016, China

2 State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China

Show Author Information

Abstract

The acute phase of ischemic stroke (IS) is characterized by rapid escalation of neuroinflammation, concomitant with disruption of tight junction proteins and increased blood-brain barrier (BBB) permeability. These pathological alterations facilitate the influx of circulating immune components and inflammatory signals into the injured brain regions, thereby exacerbating neuronal death and neurological dysfunction. Ginkgo biloba leaves have been shown to possess well-established therapeutic properties against IS. Ginkgo biloba leaf-derived exosome-like nanoparticles (GELNs) preserve the bioactive constituents of their source material and exhibit favorable biocompatibility, positioning them as a promising therapeutic modality for IS. However, their low brain-targeting capability limits their clinical translation. To overcome this limitation, we used the microthrombus-targeting peptide CREKA to surface-modify GELNs, successfully constructing CREKA-GELNs. Following tail vein injection, CREKA-GELNs can specifically target cerebral microthrombi and pass through the damaged BBB into the brain parenchyma to exert anti-inflammatory and neuroprotective effects. In addition, it can promote the structural repair of the damaged BBB; notably, once the BBB is significantly repaired, the accumulation of CREKA-GELNs in the brain decreases accordingly. Collectively, this nanoparticle delivery platform offers a safe, effective and controllable strategy for the treatment of IS.

References

【1】
【1】
 
 
Nano Research

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhao B, Jiang X, Li W, et al. Brain-targeting peptide-modified Ginkgo biloba leaf-derived exosome-like nanoparticles for ischemic stroke therapy. Nano Research, 2026, https://doi.org/10.26599/NR.2026.94909319

65

Views

10

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 17 July 2026
Revised: 06 November 2026
Accepted: 10 November 2026
Available online: 10 November 2026

© The Author(s) 2026. Published by Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0, https://creativecommons.org/licenses/by/4.0/)